LIGAND PHARMACEUTICALS INCORPORATED: capex
| Value | {"amount": 261000, "concept": "us-gaap:PaymentsToAcquirePropertyPlantAndEquipment", "currency": "USD"} |
|---|---|
| Period | 2012-01-01 – 2012-06-30 |
| Status | current |
| Entity | LIGAND PHARMACEUTICALS INCORPORATED |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T08:53:32.930900+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/0d0c8aa1-a949-4849-b4e3-23acd7df4aac
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001193125-12-344384Retrieved: 2026-08-19T08:53:32.930900+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0000886163/capex/2012-06-30 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/0d0c8aa1-a949-4849-b4e3-23acd7df4aac
History
- no predecessors — first report